Sahajanand Medical Technologies Limited (NSE:SMT)
497.00
+4.10 (0.83%)
Nov 11, 2026, 1:30 PM IST
Sahajanand Medical Technologies Earnings Call Transcripts
Fiscal Year 2027
-
Q2 FY27 set records for revenue, EBITDA and PAT, with margin gains from operating leverage. FY27 constant-currency growth guidance is mid- to high-teens; margin expansion and new product launches remain key priorities.